NewslettersCancer Stem Cell NewsUncategorizedA Novel CD34-Specific T-cell Engager Efficiently Depletes Acute Myeloid Leukemia and Leukemic Stem Cells In Vitro and In VivoBy Justin.choi - February 16, 20220172Researchers designed a CD34/CD3 bispecific T-cell engager (BiTE) and characterized its anti-leukemia potential in vitro, ex vivo and in vivo.[Haematologica] 6445212 AAAAAAAA items 1 apa 0 default asc 1 171909 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract